Log in to save to my catalogue

Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomize...

Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomize...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6755539

Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer

Publication information

Publisher

United States: American Medical Association

More information

Scope and Contents

Contents

Tumor measurements can be used to estimate time to nadir and depth of nadir as potential surrogates for overall survival (OS).
To assess time to nadir and depth of nadir as surrogates for OS in metastatic colorectal cancer.
Pooled analysis of 20 randomized clinical trials within the Aide et Recherche en Cancerologie Digestive database, which...

Alternative Titles

Full title

Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6755539

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6755539

Other Identifiers

ISSN

2574-3805

E-ISSN

2574-3805

DOI

10.1001/jamanetworkopen.2019.11750

How to access this item